“Comparison of effectiveness and safety of topical 30% metformin versus 4% hydroquinone in the treatment of epidermal melasma”, J Pak Assoc Dermatol, vol. 34, no. 1, pp. 73–79, May 2024, doi: 10.66344/jpad.v34i1.2748.